Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

BOHS Announces Eleventh Inhaled Particles Symposium

Published: Monday, March 04, 2013
Last Updated: Sunday, March 03, 2013
Bookmark and Share
Symposium will be held in the city of Nottingham from 23 to 25 September 2013.

The British Occupational Hygiene Society (BOHS) has announced its latest Inhaled Particles symposium, the eleventh in a long line of highly successful and prestigious conferences, to be held in the city of Nottingham from 23 to 25 September 2013.

The first Inhaled Particles symposium was held at Oxford University in 1960, making the meetings the oldest ongoing international symposium series on the health effects of particles.

Over the intervening fifty years, the ten Inhaled Particles meetings have witnessed all of the key developments in occupational and public health associated with airborne particles.

In particular, the Inhaled Particles symposia have been distinguished by an integrative approach to the science of particle-mediated lung disease, involving exposure scientists, epidemiologists, toxicologists and others concerned about the harm caused by inhaling particles.

The early symposia were important in helping establish standards for dust control in coalmines in the UK and other countries, reducing the incidence of pneumoconiosis among miners.

By the 1980s and 1990s, the main emphasis had shifted to fibres, including asbestos.

Inhaled Particles XI (IPXI), to be held at Nottingham Conference Centre, at Nottingham Trent University, will take a multi-disciplinary approach, addressing topics within:
• exposure, for example controls, instrumentation and measurement
• hazards, including deposition, clearance, particokinetics, toxicology, and mechanisms of disease
• risk assessment, for example epidemiology, health impacts and links with policy.

BOHS is inviting all researchers who work on exposure, metrology, epidemiology, toxicology and risk assessment in particle-associated diseases to attend the latest meeting.

In addition, BOHS continues to invite authors to submit abstracts for oral or poster presentations. All abstracts must be submitted no later than 8 April 2013. Authors will be notified by 10 May 2013.

Key speakers will include the following.
• Dr Michael Attfield is a senior epidemiologist and expert on coal miner health. He acted as co-director in a major project to examine the relationship between lung cancer and exposure to diesel exhaust. The findings of this project led to the determination by the International Agency for Research on Cancer (IARC) that there was sufficient evidence that diesel exhaust particulate was a human carcinogen.
• Dr Derk Brouwer is a senior scientist in exposure assessment with the Dutch Organization for Applied Scientific Research TNO in the Netherlands. He is active in a wide range of international projects on assessment of worker exposure to nanoparticles. In particular his research focuses on measurement strategies and exposure modeling issues.
• Dr Vince Castranova is the Chief of the Pathology and Physiology Research Branch at the National Institute for Occupational Safety and Health (NIOSH) in Morgantown, West Virginia. His research interests have been concentrated in pulmonary toxicology and occupational lung disease. He has been coordinator of the Nanotoxicology Program in NIOSH since its inception in 2005.
• Dave Litton, a Senior Research Physicist at NIOSH in Pittsburgh, Pennsylvania, is an expert in fire detection, flame spectroscopy and optical diagnostics as well as in the measurement of combustion-generated particulate matter. For the past 12 to 15 years his research has been divided between managing combustion projects related to fire and explosion safety, and new approaches to atmospheric dusts and aerosols.

Commenting on the plans for September 2013, Professor Ken Donaldson, Chair of the IPXI Scientific Committee, said “IPXI will seek to continue its fine tradition of over fifty years, bringing together leading researchers on the adverse effects of particles on the lungs and extra-pulmonary target tissues to showcase cutting edge research and debate solutions to the challenges faced within particle research and risk assessment”.

Further information about the event, including booking forms, can be accessed at Delegates who book before 1 July 2013 will receive an “early bird” discounted rate of £540.00.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos